Rimonci Capital: A Vertical Operator VC for Disruptive Technology Companies in the Vision Science Industry
Founded in 2016, Rimonci Capital is a venture capital firm with a focus on achieving the vision of "For better vision and insight." The company specializes in capital markets and is based in Beijing, Zhuhai, and Shenzhen, China. With its primary goal centered on globally exploring, incubating, and investing in disruptive technology companies in the field of pre-clinical, clinical, and other early stages, Rimonci Capital actively drives transformation into the China market.
Positioned as a "Vertical Operator VC," Rimonci Capital abides by the principle of "consulting, connecting, and leading" to help its portfolio companies grow robustly and sustainably in the long run. This approach is facilitated through a professionally constructed industry ecosystem, deep understanding of the industry, profound management skills, and intensive work plans. The company's website can be found at http://www.rimonci.com.
Rimonci Capital aims to complete the full life cycle architecture layout in the field of vision science within ten years. Their strategy includes the establishment of the Rimonci Starlight Vision Science Incubator (including a patent fund) that focuses on laboratory research and proof of concept. This incubator will be followed by the Rimonci Stars Vision Science Venture Capital Fund (US Dollar Fund) that plays a vital role in uncovering the value of startups, perfecting product development, and conducting clinical trials. Lastly, the Rimonci Galaxy Vision Science Industry Fund (RMB Fund) will drive the localization of high-potential products and technologies into the China market, and most importantly, explore China's domestic vision science innovation.
Through its strategic approach and dedication to the vision science industry, Rimonci Capital is well-positioned to make a significant impact on the global market by exploring, incubating, and investing in disruptive technology companies. By focusing on the long-term growth of its portfolio companies and the development of a full life cycle architecture, Rimonci Capital will undoubtedly continue to foster innovation and drive transformation in the China market and beyond.